Erastin

Erastin is a ferroptosis activator by acting on mitochondrial VDAC, exhibiting selectivity for tumor cells bearing oncogenic RAS. Solutions are unstable and should be fresh-prepared.

Erastin Chemical Structure

Erastin Chemical Structure

CAS: 571203-78-6

Selleck's Erastin has been cited by 338 publications

Purity & Quality Control

Batch: Purity: 99.89%
99.89

Products often used together with Erastin

RSL3


Erastin and RSL3 as ferroptosis inducers (FINs), sensitize cancer cells (H460/A549) to ionizing radiation (IR).


Lei G, et al. Cell Res. 2020;30(2):146-162.

FIN56


Erastin and FIN56, along with other ferroptosis inducers, restore trastuzumab sensitivity in rSKBR3-breast cancer cells.


Zou Y, et al. Nat Commun. 2022 May 13;13(1):2672.

Liproxstatin-1


Liproxstatin-1 protects against ferroptosis-inducing agents, such as Erastin and RSL3 in a dose-dependent manner.


Friedmann Angeli JP, et al. Nat Cell Biol. 2014;16(12):1180-1191.

Fer-1 (Ferrostatin-1)


Ferrostatin-1 promotes reversal of Erastin-induced ferroptosis in HT-22/HT-1080 dying cells.


Tang HM, et al. Biol Open. 2019 Jun 11;8(6):bio043182.

Z-VAD-FMK


Erastin and Z-VAD-FMK combination does not block erastin-induced cell death in HS578T/MDAMB231 cells.


Che C, et al. Cell Death Dis. 2022 Feb 14;13(2):150.

Erastin Related Products

Choose Selective Ferroptosis Inhibitors

Cell Data

Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
human BJeH cells Function assay 6 h Induction of reactive oxygen species production in human BJeH cells expressing wild type RAS after 6 hrs by DCF-based flow cytometric analysis 22832321
human BJeLR cells Cytotoxic assay 10 μM 12 h Cytotoxicity against human BJeLR cells expressing RAS G12V mutant at 10 uM at 12 hrs by trypan blue staining 22832321
human BJ cells Function assay 4.6 μM Increase in intracellular oxidative species in human BJ cells expressing TERT, LT, ST and RAS G12V mutant genes cells at 4.6 uM 17568748
human BJ cells Function assay 9 μM Induction of cell death in human BJ cells expressing TERT, LT, ST and RAS G12V mutant genes cells at 9 uM. 17568748
human BJ cells Function assay Induction of cell death in human BJ cells expressing TERT, LT, ST and RAS G12V mutant genes in presence of U0126 by trypan blue exclusion method, IC50=31.2 μM. 17568748
human A673 cells Function assay Induction of cell death in human A673 cells, EC50=30 μM. 17568748
human MX2 cells Function assay Induction of cell death in human MX2 cells, EC50=18 μM. 17568748
human HOS cells Function assay Induction of cell death in human HOS cells , EC50=17 μM. 17568748
human Hs925.T cells Function assay Induction of cell death in human Hs925.T cells, EC50=17 μM. 17568748
human Hs51.T cells Function assay Induction of cell death in human Hs51.T cells, EC50=12 μM. 17568748
human EWS502 cells Function assay Induction of cell death in human EWS502 cells, EC50=10 μM. 17568748
human BJ cells Function assay Induction of cell death in TERT expressing human BJ cells, EC50=10 μM. 17568748
human TC71 cells Function assay Induction of cell death in human TC71 cells, EC50=10 μM. 17568748
human U937 cells Function assay Induction of cell death in human U937 cells, EC50=10 μM. 17568748
human SK-N-MC cells Function assay Induction of cell death in human SK-N-MC cells, EC50=10 μM. 17568748
human TC32 cells Function assay Induction of cell death in human TC32 cells 17568748
human U2OS cells Function assay Induction of cell death in human U2OS cells, EC50=6 μM. 17568748
human LNCaP cells Function assay Induction of cell death in human LNCaP cells, EC50=6 μM. 17568748
human Calu1 cells Function assay Inhibition of human Calu1 cells expressing KRAS with activating mutations by trypan blue exclusion assay, IC50=4 μM. 17568748
human SKUT cells Function assay Induction of cell death in human SKUT cells, EC50=4 μM. 17568748
human MES-SA cells Function assay Induction of cell death in human MES-SA cells, EC50=3 μM. 17568748
human SVR cells Function assay Induction of cell death in human SVR cells, EC50=2.5 μM. 17568748
human HT1080 cells Function assay Induction of cell death in human HT1080 cells in presence of PD-98059 by trypan blue exclusion method, IC50=1 μM. 17568748
human BJ cells Function assay Induction of cell death in human BJ cells expressing TERT, LT, ST and RAS G12V mutant genes cells in presence of PD-98059 by trypan blue exclusion method, IC50=0.9 μM. 17568748
human HeLa cells Function assay Induction of cell death in human HeLa cells, EC50=0.6 μM. 17568748
human CCF-STTG1 cells Function assay Inhibition of Xct in human CCF-STTG1 cells assessed as glutamate release after 2 hrs by fluorometry, IC50=0.2 μM. 26231156
Click to View More Cell Line Experimental Data

Biological Activity

Description Erastin is a ferroptosis activator by acting on mitochondrial VDAC, exhibiting selectivity for tumor cells bearing oncogenic RAS. Solutions are unstable and should be fresh-prepared.
Targets
Ferroptosis [1]
In vitro
In vitro

Erastin is selectively lethal to oncogenic RAS-mutant cell lines, and triggers a unique iron-dependent form of non-apoptotic cell death called ferroptosis. [1] [2]

Erastin binds directly to VDAC2 and causes mitochondrial damage via ROS production in an NADH-dependent manner, which induces cell death in some tumor cells harbouring activating mutations in the RAS-RAF-MEK pathway. [3]

In addition, erastin, via inducing ROS-mediated CID (Caspase-independent cell death), strongly enhances the effect of cisplatin in WT EGFR cells. [4]

Cell Research Cell lines BJ-TERT/LT/ST/RASV12 cells
Concentrations 5 or 10 μg/mL
Incubation Time 6-11 hours
Method

BJ-TERT/LT/ST/RASV12 cells are seeded in 100 mm dishes and allowed to grow overnight. Cells are treated with erastin (5 or 10 μg/ml) for 6, 8, or 11 hr. A camptothecin-treated (0.4 μg/ml) control is maintained, treated at the time of seeding for 20 hours. After the treatment, cells are harvested with trypsin/EDTA and washed once with fresh medium containing serum and then twice with phosphate-buffered saline. Cells are resuspended in 1× binding buffer. 100 μL is incubated with 5 μL of Annexin V-FITC and propidium iodiode for 15 min in the dark at room temperature. Then 400 μl of the 1× binding buffer s added and the cells analyzed by flow cytometry. Data are acquired and analyzed using Cellquest software. Only viable cells that do not stain with propidium iodiode are analzyed for Annexin V-FITC staining using the FL1 channel.

Experimental Result Images Methods Biomarkers Images PMID
Western blot GPX4 / cleaved-PARP / cleaved-caspase3 / LC3 / p62 / LDH / HMGB1 TfR1 / p-JNK / JNK / p-P38 HSPA5 / p-EIF2AK3 GRP78 27308510
Growth inhibition assay Cell survival 29348676
Immunofluorescence HMGB1 31105999
In Vivo
In vivo

Erastin is a ferroptosis activator by inhibiting voltage-dependent anion channels (VDAC2/VDAC3). It also inhibits cystine-glutamate antiporter (xCT).[5]

Animal Research Animal Models C57BL/6 mice
Dosages 10 mg/kg
Administration i.n.

Chemical Information & Solubility

Molecular Weight 547.04 Formula

C30H31ClN4O4

CAS No. 571203-78-6 SDF Download Erastin SDF
Smiles CCOC1=CC=CC=C1N2C(=O)C3=CC=CC=C3N=C2C(C)N4CCN(CC4)C(=O)COC5=CC=C(C=C5)Cl
Storage (From the date of receipt) 3 years -20°C powder Solutions are unstable. Prepare fresh or purchase small, pre-packaged sizes. Repackage upon receipt.

In vitro
Batch:

DMSO : 25 mg/mL ( (45.7 mM); Warmed with 50°C water bath; Ultrasonicated; Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Water : Insoluble

Ethanol : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Erastin | Erastin supplier | purchase Erastin | Erastin cost | Erastin manufacturer | order Erastin | Erastin distributor